Chronic alcoholization-induced damage to astroglia and intensification of lipid peroxidation in the rat brain: Protector effect of hydrated form of fullerene C60

Neurophysiology

Volumn 39, Issue 2, 2007, Pages 105-111

  Tikhomirov, Artem A ^a   Nedzvetskii, V S ^a   Lipka, M V ^a   Andrievskii, G V ^b   Klochkov, V K ^b  

^a OLES HONCHAR DNIPRO NATIONAL UNIVERSITY   (Ukraine)

^b INSTITUTE OF HYDROBIOLOGY   (Ukraine)

Author keywords

Astrocytes; Chronic alcoholization; Glialfibrillary acidic protein; Hydrated fullerenes C60; Oxidative stress

Indexed keywords

ALCOHOL; FULLERENE DERIVATIVE; GLIAL FIBRILLARY ACIDIC PROTEIN; THIOBARBITURIC ACID DERIVATIVE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL POPULATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; HIPPOCAMPUS; IMMUNOREACTIVITY; LIPID PEROXIDATION; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DETERMINATION; RAT;

EID: 34648820606     PISSN: 00902977     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11062-007-0015-8     Document Type: Article

References (34)

1. Yu. V. Burov and N. N. Vedernikova, Neurochemistry and Pharmacology of Alcoholism [in Russian], Meditsina, Moscow (1985).
2. A. Augustyniak, K. Michalak, and E. Skrzydlewska, "The action of oxidative stress induced by ethanol on the central nervous system (CNS)," Postepy Hig. Med. Dosw., 59, 464-471 (2005).
3. L. Meda, P. Baron, and G. Scarlato, "Glial activation in Alzheimer's disease: The role of A-beta and its associated proteins," Neurobiol. Aging, 22, No. 6, 885-893 (2001).
4. L. F. Eng, R. S. Ghirnikar, and Y. L. Lee, "Glial fibrillary acidic protein: GFAP-Thirty-One years (1969-2000)," Neurochem. Res., 25, Nos. 9/10, 1439-1451 (2000).
5. P. Wentzel, U. Rydberg, and U. J. Eriksson, "Antioxidative treatment diminishes ethanol-induced congenital malformations in the rat," Alcohol. Clin. Exp. Res., 30, No. 10, 1752-1760 (2006).
6. 60: Buckminsterfullerene," Nature, 318, 162-162 (1985).
7. V. I. Trefilov, D. V. Shchur, B. P. Tarasov, et al., Fullerenes as the Basis for Futuristic Materials [in Russian], Institute of Polymer Materials of the Natl. Acad. Sci. of Ukraine and Institute of Polymer Chemical Substances of the Russ. Acad. Sci., Kyiv (2001).
8. 60," Science, 254, 1183-1185 (1991).
9. L. B. Piotrovskii, "Fullerenes in biology and medicine," in: Fundamental Directions of Molecular Medicine [in Russian], Rostok, Saint Petersburg (2005), pp. 197-268.
10. G. V. Andrievsky, M. V. Kosevich, O. M. Vovk, et al., "On the production of an aqueous colloidal solution of fullerenes," J. Chem. Soc. Chem. Commun., 12, 1281-1282 (1995).
11. 60 fullerene with help of FTIR re? ectance and UV-Vis spectroscopy," Chem. Phys. Lett., 364, 8-17 (2002).
12. 60/ PVP) prevents the disturbance of long-term memory consolidation induced by cycloheximide," Fullerenes, Nanotubes, Carbon Nanostruct., 12, Nos. 1/2, 421-424 (2005).
13. 60 fullerene on amyloid β-peptide fibrillization in vitro and performance of the cognitive task," J. Nanosci. Nanotech., 7, Nos. 4/5, 1479-1485 (2007).
14. 60 fullerene as the basis for creation of a wide spectrum of products with unique bioactivity," in: Fullerenes and Atomic Clusters (St. Petersburg, June 27-July 1), Saint Petersburg (2005), p. 235.
15. V. S. Nedzvetsky, M. Tuzcu, A. Yasar, et al., "Effects of vitamin E against aluminum neurotoxicity in rats," Biochemistry, 71, No. 3, 239-244 (2006).
16. M. M. Bradford, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding," Anal. Biochem., 72, 248-254 (1976).
17. U. K. Laemmli, "Cleavage of structural proteins during the assembly of the head of bacteriophage T4," Nature, 227, 680-685 (1970).
18. H. Towbin, "Immunoblotting - an update," Biochem. Soc. Trans., 16, No. 2, 131 (1988).
19. V. I. Lushchak, T. V. Bagnyukova, and O. V. Lushchak, "Indices of oxidative stress. Thiobarbiturate-active products and carbonyl groups of proteins," Ukr. Biokhim. Zh., 76, No. 3, 136-141 (2004).
20. S. N. Lapach, A. V. Chubenko, and P. N. Babich, Statistical Techniques in Medico-Biological Studies with the Use of Excel [in Russian], Morion, Kyiv (2000).
21. S. Gemma, S. Vichi, and E. Testai, "Individual susceptibility and alcohol effects: Biochemical and genetic aspects," Ann. Ist. Super Sanita, 42, No. 1, 8-16 (2006).
22. A. I. Cederbaum, "CYP2E1 - biochemical and toxicological aspects and role in alcohol-induced liver injury," Mount Sinai J. Med., 73, No. 4, 657-672 (2006).
23. G. Baydas, A. Yasar, and M. Tuzcu, "Comparison of the impact of melatonin on chronic ethanol-induced learning and memory impairment between young and aged rats," J. Pineal Res., 39, No. 4, 346-352 (2005).
24. L. L. Dugan, E. G. Lovett, K. L. Quick, et al., "Fullerene-based antioxidants and neurodegenerative disorders," Parkinsonism Relat. Disord., 7, 243-246 (2001).
25. 60," Toxicol. Lett., 93, 29-37 (1997).
26. L. L. Dugan, D. M. Turetsky, C. Du, et al., "Carboxyfullerenes as neuroprotective agents," Proc. Natl. Acad. Sci. USA, 94, 9434-9439 (1997).
27. 60-fullerene adducts inhibit neuronal nitric oxide synthase by acting as highly potent calmodulin antagonist," Arch. Biochem. Biophys., 399, No. 2, 130-141 (2002).
28. N. Gharbi, M. Pressac, M. Hadchouel, et al., "[60] Fullerene is an in vivo powerful antioxidant with no acute or sub-acute toxicity," NanoLett., 5, No. 12, 2578-2585 (2005).
29. 60 fullerene molecule toxic?" Fullerenes, Nanotubes, Carbon Nanostruct., 13, No. 4, 363-376 (2005).
30. J. J. Miguel-Hidalgo, "Lower packing density of glial fibrillary acidic protein-immunoreactive astrocytes in the prelimbic cortex of alcohol-naive and alcohol-drinking alcohol-preferring rats as compared with alcohol nonpreferring and Wistar rats," Alcohol. Clin. Exp. Res., 29, 766-772 (2005).
31. P. L. Hoffman, M. Miles, H. J. Edenberg, et al., "Gene expression in brain: A window on ethanol dependence, neuroadaptation, and preference," Alcohol. Clin. Exp. Res., 27, 155-168 (2003).
32. 60 in PC12 cells," Life Sci., 66, No. 16, 1525-1533 (2000).
33. K. Kaneko, A. Nakamura, K. Yoshida, et al., "Glial brillary acidic proteinis greatly modi?ed by oxidative stress in aceruloplasminemia brain," Free Rad. Res., 36, No. 3, 303-306 (2002).
34. G. Baidas, E. Donder, M. Kiliboz, et al., "Neurodefense by α-lipoic acid in streptozotocin-induced diabetes," Biokhimia, 69, No. 9, 1233-1238 (2004).